Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Novel HCV NS5A inhibitor shows proof of concept in nonhuman primates

March 28, 2012

First descriptions provided of BMS products now in phase II testing

March 27, 2012

Merck & Co. selects new agent for development in diabetes

March 27, 2012

New boron-based ROCK inhibitors show potential to treat inflammation and hypertension

March 27, 2012

U.S. study reveals new prognostic marker of aggressive kidney cancer

March 27, 2012

Promising data disclosed on apremilast in psoriasis and atopic dermatitis

March 27, 2012

New product extends therapeutic window of t-PA in stroke model

March 26, 2012

Toray evaluates 11-beta-HSD1 inhibitor in obesity and diabetes models

March 26, 2012

Durable submental fat reduction seen with ATX-101

March 26, 2012

New Wnt/catenin beta signaling inhibitor shows potential as cancer therapy

March 26, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...